X4 Pharmaceuticals XFOR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 4.13 | 112.14 | -0.16 | -20,306 | -20 | |
| 2025Q4 | 4 | 109.02 | 1 | -23,699 | -24 | |
| 2025Q3 | 3.42 | 99.71 | -0.69 | -27,509 | -30 | |
| 2025Q2 | 1.9 | 0.75 | -3.47 | -26,232 | -26 | |
| 2025Q1 | 7.09 | -375.17 | 0.04 | -9,443 | 0 | |
| 2024Q4 | 22.01 | 95.86 | -5.94 | -35,715 | -40 | |
| 2024Q3 | 20.08 | 100.68 | 6.4 | -5.4 | -34,500 | -37 |
| 2024Q2 | 17.4 | 76.43 | 13.47 | 71,103 | 91 | |
| 2024Q1 | 41.7 | 74.77 | -7.77 | -37,289 | -52 | |
| 2023Q4 | 25.16 | 146.41 | -2.67 | -25,199 | -19 | |
| 2023Q3 | 32.7 | 4219.22 | 0.9 | -27,214 | -2 | |
| 2023Q2 | 58.2 | 47.31 | -10.5 | -25,805 | -56 | |
| 2023Q1 | 26.1 | 127.93 | -4.8 | -29,304 | -24 | |
| 2022Q4 | 29.79 | 91.52 | -6 | -25,577 | -29 | |
| 2022Q3 | 51.3 | 97.93 | -0.3 | -20,154 | -22 | |
| 2022Q2 | 28.95 | 101.38 | -17.7 | -20,570 | -21 | |
| 2022Q1 | 52.5 | 101.14 | -21.6 | -21,268 | -22 | |
| 2021Q4 | 68.7 | 99.23 | -38.4 | -29,055 | -30 | |
| 2021Q3 | 158.7 | 99.3 | -22.2 | -19,119 | -20 | |
| 2021Q2 | 195 | 101.45 | -20.1 | -18,997 | -20 |